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Abstract
Deafness is one of the most common communication disorders in humans. Approximate‐
ly one out of every thousand infants is born with a significant hearing deficit. The preva‐
lence of hearing loss increases dramatically with age. By age 65 years, one out of three of
us will suffer from hearing impairment sufficient to interfere with the understanding of
speech. Hearing impairment is a very heterogeneous disorder with a wide range of caus‐
es. Worldwide, estimates from the World Health Organization are that hearing loss af‐
fects 538 million people. Hearing loss may be classified into three types: sensorineural,
involving the inner ear, cochlea, or the auditory nerve; conductive, when the outer or
middle ear structures fail to optimally capture, collect, or transmit sound to the cochlea;
and mixed loss, which is a combination of conductive and sensorineural hearing loss. In
this chapter, we propose to briefly define each cause of hearing loss as follows: (1) outer
ear causes (congenital, infection, trauma, tumor, dermatologic, and cerumen), (2) middle
ear causes (congenital, eustachian tube dysfunction, infection, tumors, otosclerosis, tym‐
panic membrane perforation, middle ear barotrauma, and vascular), and (3) inner ear
causes (congenital or hereditary, presbycusis, infection, Ménière disease, noise exposure,
inner ear barotrauma, trauma, tumors, endocrine/systemic/metabolic, autoimmune hear‐
ing loss, Iatrogenic, ototoxic, and neurogenic).
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1. Introduction
Deafness is one of the most common communication disorders in humans. Approximately one
out of every thousand infants is born with a significant hearing deficit, and the prevalence of
hearing loss increases dramatically with age. By age 65 years, one out of three of us will suffer
from hearing impairment sufficient to interfere with the understanding of speech. Hearing
impairment is a very heterogeneous disorder with a wide range of causes.[1]
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Worldwide, estimates from the World Health Organization are that hearing loss affects 538
million people.[1]
Hearing loss may be classified into three types:
• Sensorineural: involving the inner ear, cochlea, or the auditory nerve
• Conductive: when the outer or middle ear structures fail to optimally capture, collect, or
transmit sound to the cochlea
• Mixed loss: a combination of conductive and sensorineural hearing loss
2. Outer ear causes
The outer ear comprises the auricle and the external auditory canal (EAC), and all hearing loss
related to the outer ear is by nature a conductive hearing loss.
2.1. Cerumen
Probably the most common cause of conductive hearing loss is the complete blockage of the
EAC by a cerumen impaction. Some patients are not able to clear it on their own or use Q-tips
that push the cerumen down the ear canal. These individuals may need periodic cleaning to
enhance their auditory capabilities.
2.2. Infection
Infections may lead to blockage of the EAC due to the accumulation of debris, edema, or
inflammation. Acute otitis externa usually develops as a result of local trauma coupled with
contamination by bacteria (or occasionally fungi—otomycosis or viral—herpes zoster oticus)
after swimming, showering, or exposure to hot and humid conditions. With complete
obstruction, a conductive hearing loss results. Diabetes mellitus and other immunocompro‐
mised states can predispose to developing malignant otitis externa.[2]
2.3. Congenital
The auricle and the EAC are derived from different embryologic tissue, and each may develop
without the full maturation of the other sites. The EAC develops from the 8th to the 28th week
of gestation, and the auricle itself forms from remnants of the first and second branchial arch
during the 12th and 20th weeks. Problems can occur anytime during this developmental phase,
and it is possible to have a normal auricle but an atretic canal. The anatomical course of the
facial nerve is frequently altered in malformations of the ear and temporal bone, but facial
nerve function is rarely affected by the malformation. Conductive hearing losses that result
from congenital malformations may range from mild to severe.
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Malformation of the auricle is termed anotia when there is complete absence of an external ear
and microtia when there is a vestige present. Anotia and microtia may cause mild to moderate
conductive hearing loss.[2]
Congenital atresia of the EAC occurs in approximately 1 per 10,000 births and are usually
associated with other craniofacial abnormalities such as Treacher–Collins syndrome, Pierre
Robin syndrome, or Crouzon disease. The malformation occurs unilaterally 4 times more
frequently than it does bilaterally (Figure 1).[3]
The severity of the atresia determines how well the child hears, and some patients with
congenital atresia have associated inner-ear abnormalities, but these abnormalities typically
do not cause sensorineural hearing loss. Atresia or significant stenosis of the EAC causes
moderate to severe conductive hearing loss.[3]
Figure 1. Congenital atresia of the EAC
2.4. Tumors
Malignant cancer of the ear canal is rare, and the most common histology type is squamous
cell carcinoma. Other tumors include basal cell carcinoma, adenoid cystic carcinoma, adeno‐
carcinoma, and melanoma. Initially, cancer of the EAC is usually misdiagnosed as otitis externa
because most patients complain of otorrhea, aural fullness, pain, itching, and hearing loss.
However, after multiple failed attempts at treatment with ototopical drops and antibiotics, a
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biopsy of the EAC should be obtained. Treatment of these malignant tumors varies with the
specific neoplasm.[4]
Benign bony growths may also occlude the EAC with a resulting conductive hearing loss. The
two most common benign growths are exostosis and osteoma.
Exostosis are the most common solid tumor of the EAC. They are periosteal outgrowths that
develop in the bony ear canal and occur mostly in men who have had repeated exposure to
cold water. The lesions are often multiple, bilateral, and form in the suture lines of the EAC
bones. Surgical removal is performed in cases of conductive hearing loss or recurrent otitis
externa.[5]
Osteoma, in contrast, is a solitary bony growth that is most commonly attached to the tympa‐
nosquamous suture line. Similar to exostoses, osteomas are not treated until they become so
large that they affect hearing by occlusion or repeated infections because debris cannot exit
the EAC.[6]
Benign polyps may occur as a result of other otologic conditions, such as chronic ear infections
or cholesteatoma. Occasionally, benign polyps can grow large enough to occlude the lumen
of the external auditory canal.
2.5. Trauma
Penetrating trauma to the external auditory canal or meatus due to bullet, knife, or fracture
may cause mild or profound conductive hearing loss, depending on the degree of EAC
occlusion. Ototopical drops prevent otitis externa, and external auditory canal stenting is
required initially to ensure that the EAC does not develop significant stenosis. Surgical
intervention is reserved for cases of stenosis.
3. Middle ear causes
As with the outer ear, all hearing loss associated with the middle ear is conductive hearing
loss.
3.1. Congenital malformation
Malformation of the ossicular chain can cause conductive hearing loss. The most common
ossicular abnormality observed is a missing or malalignment of the crura of the stapes.
However, it is usually an abnormal incus or malleoincudal joint that causes the conductive
hearing loss. Computed tomography (CT) scan is virtually always needed in order to make
this diagnosis, and in some cases, exploratory tympanostomy may be required.[2]
3.2. Eustachian tube dysfunction
The eustachian tube serves to provide normal middle ear pressure when opened and to protect
the middle ear from reflux and nasopharyngeal bacteria when closed. Abnormal function
Update On Hearing Loss42
occurs commonly in the setting of an upper respiratory infection (viral or bacterial), and it can
also occur with allergies or tumors. It results in negative middle ear pressure causing reduction
of tympanic membrane (TM) excursion and conductive hearing loss.
3.3. Infection
Acute otitis media (AOM) is a common childhood disorder that also frequently occurs in
adults. Approximately 80% to 90% of all children will have developed at least one episode of
OM by the time they enter school, and AOM accounts for more than 25% of the prescriptions
for oral antibiotics annually.[7]
It is normally associated with pain, fever, and ear fullness as well as decreased hearing.
Conductive hearing loss occurs because fluid filling the middle ear space prevents the TM
from vibrating adequately, thereby diminishing movement of the ossicular chain.[8]
The middle ear may still be filled with serous or thick, tenacious fluid after the acute infection
has been successfully treated. This fluid resolves within four to six weeks in 70% of cases. By
an additional 12 weeks, 85% to 90% of all resolve the condition on their own. However, in the
10% to 15% in whom the fluid does not clear, it needs to be removed and the middle ear aerated
in order to promote resolution of any conductive hearing loss. The fluid is usually cleared by
either myringotomy and pressure equalization tube placement, or myringotomy and aspira‐
tion.[9]
3.4. Tympanic membrane perforation
Conductive hearing loss due to TM perforation is common. Clearly, the size, location, and
nature of perforation will affect the degree of hearing loss. Small perforations and those located
in the anterior–inferior quadrant cause the least amount of conductive hearing loss; near total
or posterior–superior quadrant perforations have a much higher chance of causing significant
hearing loss.[10]
Tympanic membrane perforations can arise as a consequence of either infection or trauma.
Most perforations heal spontaneously. Occasionally, surgical correction is required, and repair
of the perforation often corrects the conductive hearing loss.[7]
3.5. Otosclerosis
Otosclerosis is a primary disease of the temporal bone, leading to stapes ankylosis. Hearing
loss is the main symptom. Complaints of continuous tinnitus and, eventually, vertigo are also
observed. Otosclerosis is considered an autosomal dominant disease with incomplete pene‐
trance being identified in three related genes: OTSC 1, OTSC 2, and OTSC 3. Treatment includes
surgery, medical treatment, and sound amplification therapy alone or in combination.
3.6. Cholesteatoma
Cholesteatoma is a growth of desquamated, stratified, squamous epithelium within the middle
ear space. Such collections of desquamated skin cells will erode bone slowly through a
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combination of pressure necrosis and enzymatic activity. Infection accelerates the process of
bony destruction. The formation of a cholesteatoma typically occurs after a retraction pocket
has formed in the posterior/superior quadrant, often the result of poor eustachian tube
function. It may also occur after tympanic membrane trauma, such as a traumatic, inflamma‐
tory, or iatrogenic perforation, with implantation of squamous cells.[11]
Conductive hearing loss can occur as one or all ossicles become destroyed. Left untreated,
cholesteatomas may erode the tegmen, the sigmoid sinus, or even the inner ear, resulting in
labyrinthine fistula, which causes severe or profound sensorineural hearing loss and vertigo.
Thus, untreated, they can cause lateral sinus thrombosis, sepsis, brain abscess, facial paralysis,
and even death. Treatment is surgical, usually involving a mastoidectomy.[7]
3.7. Neoplasm
Malignant tumors such as Langerhans cell histiocytosis or squamous cell carcinoma may also
occur in the middle ear and can cause conductive hearing loss. However, these entities are
relatively rare when compared with cholesteatoma.
3.8. Middle ear barotrauma
Barotrauma occurs when a patient is exposed to a sudden, large change in ambient pressure,
often during diving or flying. Middle ear pressure becomes more positive with respect to
ambient pressure during ascent until the eustachian tube is forced open. On descent, ambient
pressure exceeds middle ear pressure until swallowing opens the eustachian tube.
Pressure in the middle ear normally equilibrates with ambient pressure via the eustachian
tube. However, if upon descent with flying or diving this equalization is prevented by mucosal
edema secondary to an upper respiratory infection, pregnancy, or anatomic variations, the
negative relative pressure in the middle ear can lead to its filling with serous fluid or blood or
to inward rupture of the TM. Symptoms vary from a sensation of pressure to hearing loss and
pain, which may suddenly be relieved with rupture of the TM.[12]
Overpressurization of the middle ear can occur during ascent with flying or diving, but TM
rupture is rare.
3.9. Vascular
Glomus tumors are the most common benign neoplasm of the middle ear. They arise from
paraganglionic tissue from the promontory of the middle ear or the adventitia of the dome of
the jugular bulb and may rarely show malignant potential.[8]
As tympanic tumors grow, they tend to fill the middle ear, with resultant pulsatile tinnitus
with or without conductive hearing loss. They also erode bone as they enlarge, especially
inferiorly, causing damage to cranial nerves. In addition, tumors may impede upon the
ossicular chain and TM, thereby decreasing motility of either or both structures.[2]
Treatment may include surgical resection, embolization, and radiation.
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4. Inner ear causes
Disorders of the inner ear normally cause a sensorineural hearing loss. The etiology may be
associated with the cochlea, eighth nerve, internal auditory canal, or brain.
4.1. Congenital or hereditary
Congenital hearing loss will be defined as any hearing loss that occurs at or shortly after birth
that may be due to either a hereditary or nonhereditary cause. Nonhereditary etiologies
involve an insult to the developing cochlea, including viral infections such as cytomegalovirus,
hepatitis, rubella, toxoplasmosis, HIV, and syphilis. Some teratogenic medications may also
affect the developing ear of the fetus, including recreational drugs, alcohol, quinine, and
retinoic acid.[2]
Sensorineural hearing loss can be inherited in an autosomal dominant or recessive pattern;
90% is autosomal recessive, so that the children often have normal hearing parents. Sensori‐
neural hearing loss also may be part of a syndrome or occur as a spontaneous mutation. The
hearing deficit may be present at birth, be progressive from birth, or present when the child is
older, or even early adult life. The most common testable genetic defect is an abnormal
connexin 26.[1]
Congenital malformations of the inner ear also occur, these include anything from complete
atresia to a common cavity of the cochlea. The most common malformation is a Mondini, where
the normal two-and-one-half turns of the cochlea are replaced by one to one-and-one-half
turns.
Patients who have congenital anomalies of either the inner or the middle ear may also develop
perilymphatic fistulas (PLFs). PLFs alone can cause progressive or fluctuating sensorineural
hearing loss.
4.2. Presbycusis
Presbycusis, or age-related hearing loss, is a common cause of hearing loss worldwide. This
disorder is a complex and multifactorial, characterized by symmetrical progressive loss of
hearing over many years. It usually affects the high frequencies of hearing, although its
presentation and clinical course can be variable. Presbycusis has a tremendous impact on the
quality of life of millions of older individuals and is increasingly prevalent as the population
ages.[8]
Common complaints associated with presbycusis include the inability to hear or understand
speech in a crowded or noisy environment, difficulty understanding consonants, and the
inability to hear high pitched voices or noises. Tinnitus is often present.[2]
The prevalence of hearing loss increases with age, with up to 80% of functionally significant
hearing loss occurring in older adults.
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The World Health Organization (WHO) estimates that in 2025, there will be 1.2 billion people
over 60 years of age worldwide, with more than 500 million individuals who will suffer
significant impairment from presbycusis.
Hearing aids are able to benefit most patients with presbycusis, and cochlear implantation
may benefit patients of any age who are not helped by hearing aids.
4.3. Infection
The most common infection of the inner ear is viral cochleitis in adults and meningitis in young
children. Meningitis can access the cochlea by way of CSF-perilymph fluid connection and
cause a profound sensorineural hearing loss by destroying the inner ear hair cells. Viral
cochleitis usually manifests as a sudden sensorineural hearing loss and vertigo.[2]
Other causes of sudden sensorineural hearing loss include acoustic neuroma, perilymphatic
fistula, Ménière disease, vascular insufficiency, multiple sclerosis, and other central etiologies.
Although the primary etiology of sudden sensorineural hearing loss is almost always viral or
a vascular ischemic event, patients with this presentation need to undergo audiometric
evaluation as well as a magnetic resonance imaging (MRI) with gadolinium.
4.4. Ménière`s disease
Ménière`s disease is characterized by (1) spontaneous episodes of vertigo lasting several
minutes to hours, (2) low-pitched tinnitus occurring or worsening during a vertiginous attack,
(3) fluctuating low-frequency sensorineural hearing loss, and (4) aural fullness in the affected
ear.[8]
The onset of symptoms is typically between the third and sixth decades, with a slight female
preponderance. Endolymphatic hydrops is the main histopathologic correlate. Over time and
with repeated attacks, the hearing deficit can become permanent and may even eventually
involve all frequencies.
4.5. Noise exposure
Everyday noise exposure, compounded over time, has an impact upon our ability to hear.
Constant exposure to loud noises can cause high-frequency sensorineural hearing loss,
beginning with selective loss in 4000 Hz. With continued exposure, the notch widens and
affects all high frequencies. Eventually, hearing loss can be seen in middle and lower frequen‐
cies. A short blast of loud noise also can cause severe to profound sensorineural hearing loss,
pain, or hyperacusis. This usually involves exposure to noise greater than 120 to 155 dB.[2]
The mechanism by which excessive noise induces hearing loss includes direct mechanical
damage of cochlear structures and metabolic overload due to overstimulation. Some potential
metabolic effects are excess nitric oxide release that can damage hair cells, generation of oxygen
free radicals that become toxic to membranes, and low magnesium concentrations that weaken
hair cells by reducing the concentration of intracellular calcium.
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Thus, hearing protection in the form of muffs or plugs is highly recommended anytime a
person is exposed to loud noise.
4.6. Inner ear barotrauma
Barotrauma occurs when a patient is exposed to a sudden, large change in ambient pressure,
often during diving or flying.
Inner ear barotrauma is a fairly uncommon injury but should be excluded in all cases of middle
ear barotrauma. It can occur following the development of a sudden pressure differential
between the inner and middle ear, leading to rupture of the round or oval window. The main
symptoms are tinnitus, vertigo, and hearing loss. The resulting labyrinthine fistula and leakage
of perilymph can result in permanent inner ear damage. The primary treatment of this
complication is complete bed rest with head elevation to avoid increases in cerebrospinal fluid
pressure. Deteriorating inner ear function generally requires tympanotomy and patching of
the round or oval window.[2]
4.7. Trauma
Blunt trauma can result in sensorineural loss due to concussive forces of the inner ear fluids,
which may cause a shearing affect on the cochlear organ of Corti. Blunt trauma may also lead
to longitudinal or transverse temporal bone fracture.
The longitudinal type is most common (80%). It is usually caused by a blow to the temporal
parietal region. Hearing loss is typically conductive and associated with tympanic membrane
(TM) perforations and blood in the middle ear space.
A transverse fracture occurs following a blow to the occipital or frontal region (Figure 2).
Fractures of this type usually run through the inner ear. If hearing is preserved to some degree,
the most common reason for a conductive hearing loss is an ossicular injury, typically due to
separation of the incudal stapedial joint and/or incus dislocation.[2]
Penetrating trauma typically causes sensorineural or mixed hearing loss. These injuries are
usually due to gunshot wounds that upon impact cause significant temporal bone fractures.
4.8. Tumors
Most tumors of the inner ear are benign, although malignant tumors such as squamous cell
carcinoma, sarcomas, adenoid carcinoma, and metastasis rarely occur. Benign bony tumors,
including fibrous dysplasia and Paget disease, are also rare.[2]
The most common tumor that causes sensorineural hearing loss is an acoustic neuroma. Eighty
percent of tumors arising in the cerebellopontine angle are acoustic neuroma. This is a benign
tumor that usually arises from the Schwann’s cells of the vestibular portion of the eighth cranial
nerve. The most common complaint is an asymmetric progressive sensorineural hearing loss,
which typically begins in the high frequencies and progresses to involve lower frequencies.
Other symptoms include unilateral tinnitus, disequilibrium, dizziness, or headaches.[8]
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4.9. Endocrine disorders
Various metabolic abnormalities have been known to either cause or be associated with
sensorineural hearing loss. Thus, an evaluation of an unexplained sensorineural hearing loss
should involve a complete laboratory evaluation to include the following: complete blood
count with differential, blood sugar, thyroid function tests, and serologic test for syphilis.[2]
Diabetes has been associated with an approximately twofold increase in the prevalence of low-
and midfrequency hearing impairment in adults; this might relate to the impact of diabetes on
the vascular or neural components of the inner ear.[8]
Anemia or a white blood cell dyscrasia may lead to sensorineural hearing loss by an unknown
mechanism that may involve decreased oxygenation, microblockage of vessels, or infection.
4.10. Autoimmune hearing loss
The autoimmune inner ear disease may be limited just to the ear, or it may be part of an overall
systemic problem. Approximately one third of patients will have evidence of systemic
autoimmune disorder such as Wegener granulomatosis, Cogan syndrome, rheumatoid
arthritis, systemic lupus erythematosus, or polyarteritis nodosa.[2]
Autoimmune hearing loss is usually sensorineural, bilateral, and asymmetric, which is either
fluctuating or progressive in nature.
The treatment choice for patients with autoimmune inner ear disease is high-dose glucocorti‐
coids for up to 4 weeks. This often results in significant recovery of hearing.[2]
Figure 2. Transverse temporal bone fracture
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Cytotoxic medications such as cyclophosphamide, methotrexate, or azathioprine may be used
if corticosteroids fail.
4.11. Ototoxicity
A great number of medications are known to cause damage to the ear. Anti-inflammatory,
antibiotics, loop diuretics, antimalarials, chemotherapeutic agents, and ototopical medications
may cause ototoxicity (Table 1).[8]
The hearing loss caused by antibiotic or chemotherapeutic agents usually begins at high
frequencies, and with continued medication use, the hearing loss will become more pro‐
nounced and may even continue to worsen for a time after the drug is discontinued.
Several antibiotics cause ototoxicity. All oral aminoglycosides are ototoxic, and this effect is
due to hair cell death from apoptosis. Different types of aminoglycosides show different
patterns of ototoxicity. Streptomycin and gentamicin are primarily vestibulotoxic. Neomycin,
amikacin, and tobramycin are primarily cochleotoxic.
Ototopical aminoglycoside drops have the potential to cause ototoxicity. However, it is
believed that these medications do not have their normal ototoxic effect because the inflamed
mucosa within the ear prevents significant drug penetration into the oval and round windows.
Other oral antibiotics that can cause ototoxicity include erythromycin and tetracycline.
Medications Effects
Antibiotics Aminoglycosides
Streptomycin
Gentamicin
Neomycin
Amikacin
Tobramycin
Macrolides
Erythromycin
Glycopeptides
Vancomycin
Vestibulotoxic
Vestibulotoxic
Cochleotoxic
Cochleotoxic
Vestibulotoxic and cochleotoxic
Cochleotoxic
Cochleotoxic (synergism with aminoglycosides)
Anti-inflammatory Aspirin (salicylates) Cochleotoxic
Loop diuretics Furosemide Cochleotoxic (synergism with aminoglycosides)
Antimalarials Quinine
Chloroquine
Cochleotoxic
Cochleotoxic
Chemotherapeutic agents Cisplatin Cochleotoxic
Ototopical drops Aminoglycoside drops (gentamicin
and neomycin)
Potential ototoxicity in tympanic membrane
perforation
Table 1. Medications related with ototoxicity
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Many chemotherapeutic agents are known to cause hearing loss. These include cisplatin, 5-
fluorouracil (5-FU), bleomycin, and nitrogen mustard. The worst ototoxicity occurs with
cisplatin, which damage the outer hair cells of the basal turn of the cochlea, causing bilateral,
symmetric, and high-frequency hearing loss.
High-dose aspirin (6–8 g/day) or other salicylates can cause a flat mild-to-moderate sensori‐
neural hearing loss, but this is reversible with discontinuation of the drug.
Antimalarial medications such as quinine and chloroquine may also cause sensorineural
hearing loss and tinnitus, but similar to salicylates, these effects are usually reversible. This is
also true for high-dose nonsteroidal anti-inflammatory agents. Loop diuretics are an additional
cause of temporary hearing loss and tinnitus.[2]
Heavy metals, including lead, mercury, cadmium, and arsenic, can all lead to hearing loss.
4.12. Neurogenic
Several neurologic disorders may cause sensorineural hearing loss: cerebrovascular accident
or transient ischemic attack, Arnold–Chiari malformations (may stretch the auditory vestibu‐
lar nerve, thereby causing hearing loss and/or vestibular complaints), and multiple sclerosis
(can initially present as a sudden sensorineural hearing loss and/or vertigo). 2
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